Follow
Prof. Yossi (Joseph) Tam
Prof. Yossi (Joseph) Tam
Head, Obesity and Metabolism Laboratory, The Hebrew University of Jerusalem
Verified email at mail.huji.ac.il - Homepage
Title
Cited by
Cited by
Year
Peripheral cannabinoid receptor, CB2, regulates bone mass
O Ofek, M Karsak, N Leclerc, M Fogel, B Frenkel, K Wright, J Tam, ...
Proceedings of the National Academy of Sciences 103 (3), 696-701, 2006
6512006
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
J Tam, VK Vemuri, J Liu, S Bátkai, B Mukhopadhyay, G Godlewski, ...
The Journal of clinical investigation 120 (8), 2953-2966, 2010
5122010
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
T Jourdan, G Godlewski, R Cinar, A Bertola, G Szanda, J Liu, J Tam, ...
Nature medicine 19 (9), 1132-1140, 2013
3822013
Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance
J Tam, R Cinar, J Liu, G Godlewski, D Wesley, T Jourdan, G Szanda, ...
Cell metabolism 16 (2), 167-179, 2012
3452012
Depression induces bone loss through stimulation of the sympathetic nervous system
R Yirmiya, I Goshen, A Bajayo, T Kreisel, S Feldman, J Tam, V Trembovler, ...
Proceedings of the National Academy of Sciences 103 (45), 16876-16881, 2006
2732006
Endocannabinoids in liver disease
J Tam, J Liu, B Mukhopadhyay, R Cinar, G Godlewski, G Kunos
Hepatology 53 (1), 346-355, 2011
2252011
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling
J Tam, V Trembovler, V Di Marzo, S Petrosino, G Leo, A Alexandrovich, ...
The FASEB journal 22 (1), 285-294, 2008
2232008
Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice
J Liu, L Zhou, K Xiong, G Godlewski, B Mukhopadhyay, J Tam, S Yin, ...
Gastroenterology 142 (5), 1218-1228. e1, 2012
1852012
Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling
J Tam, O Ofek, E Fride, C Ledent, Y Gabet, R Müller, A Zimmer, K Mackie, ...
Molecular pharmacology 70 (3), 786-792, 2006
1812006
Endocannabinoids and the regulation of bone metabolism
I Bab, O Ofek, J Tam, J Rehnelt, A Zimmer
Journal of neuroendocrinology 20, 69-74, 2008
1602008
Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasingde novosynthesis of long-chain ceramides
R Cinar, G Godlewski, J Liu, J Tam, T Jourdan, B Mukhopadhyay, ...
Hepatology 59 (1), 143-153, 2014
1592014
Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span
M Grunewald, S Kumar, H Sharife, E Volinsky, A Gileles-Hillel, T Licht, ...
Science 373 (6554), eabc8479, 2021
1572021
Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet
S Srivastava, Y Kashiwaya, MT King, U Baxa, J Tam, G Niu, X Chen, ...
The FASEB Journal 26 (6), 2351, 2012
1362012
Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy
T Jourdan, G Szanda, AZ Rosenberg, J Tam, BJ Earley, G Godlewski, ...
Proceedings of the National Academy of Sciences 111 (50), E5420-E5428, 2014
1252014
The case for peripheral CB1 receptor blockade in the treatment of visceral obesity and its cardiometabolic complications
G Kunos, J Tam
British journal of pharmacology 163 (7), 1423-1431, 2011
1232011
miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression
G Hanin, N Yayon, Y Tzur, R Haviv, ER Bennett, S Udi, ...
Gut 67 (6), 1124-1134, 2018
1102018
Lower circulating endocannabinoid levels in children with autism spectrum disorder
A Aran, M Eylon, M Harel, L Polianski, A Nemirovski, S Tepper, ...
Molecular autism 10 (1), 1-11, 2019
1092019
Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver
B Mukhopadhyay, R Cinar, S Yin, J Liu, J Tam, G Godlewski, ...
Proceedings of the National Academy of Sciences 108 (15), 6323-6328, 2011
1062011
Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects
G Godlewski, SO Alapafuja, S Bátkai, SP Nikas, R Cinar, L Offertáler, ...
Chemistry & biology 17 (11), 1256-1266, 2010
972010
Metabolic circuit involving free fatty acids, microRNA 122, and triglyceride synthesis in liver and muscle tissues
C Chai, M Rivkin, L Berkovits, A Simerzin, E Zorde-Khvalevsky, ...
Gastroenterology 153 (5), 1404-1415, 2017
962017
The system can't perform the operation now. Try again later.
Articles 1–20